Patents by Inventor Chiao-Ling HSU

Chiao-Ling HSU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230307377
    Abstract: A self-aligned multiple patterning mark is provided. The mark includes a group of patterns disposed on the substrate and a cover layer. The group of patterns includes a plurality of strip patterns extending in a first direction and arranged parallel to each other, and the ends of two adjacent strip patterns are connected to each other to form an independent ring. The cover layer is disposed on the substrate and covers the group of patterns. The cover layer has an opening extending in a second direction across the first direction, and the cover layer covers two opposite ends of each strip pattern.
    Type: Application
    Filed: February 21, 2023
    Publication date: September 28, 2023
    Applicant: Winbond Electronics Corp.
    Inventors: Chiao-Ling Hsu, Li-Chien Wang
  • Patent number: 10940113
    Abstract: A pharmaceutical composition for colon targeting, a method for treating a colon-related disease using the same and a preparation method thereof are disclosed. The pharmaceutical composition of the present disclosure comprises: a core matrix comprising a cross-linked hydrogel and an active ingredient, wherein the active ingredient is dispersed in the cross-linked hydrogel, and a content of the active ingredient is 65 wt % to 95 wt % based on a total weight of the core matrix.
    Type: Grant
    Filed: February 22, 2018
    Date of Patent: March 9, 2021
    Assignee: MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
    Inventors: Chih-Chiang Yang, Wen-Che Wang, Chiao-Ling Hsu
  • Publication number: 20180243220
    Abstract: A pharmaceutical composition for colon targeting, a method for treating a colon-related disease using the same and a preparation method thereof are disclosed. The pharmaceutical composition of the present disclosure comprises: a core matrix comprising a cross-linked hydrogel and an active ingredient, wherein the active ingredient is dispersed in the cross-linked hydrogel, and a content of the active ingredient is 65 wt % to 95 wt % based on a total weight of the core matrix.
    Type: Application
    Filed: February 22, 2018
    Publication date: August 30, 2018
    Inventors: Chih-Chiang YANG, Wen-Che WANG, Chiao-Ling HSU